Investing.com -- Citigroup downgraded CME Group Inc (NASDAQ:CME) to "neutral" on expectations of slower growth following two years of double-digit top-line expansion.
“After two solid years of double-digit top-line growth, we expect to see more muted growth this year,” analyst said.
The firm forecasts a more muted 4% revenue growth in 2025, despite strong fundamentals in rates and energy markets. Citi noted CME’s defensive appeal in a volatile environment but prefers a better entry point or clearer catalysts for fresh investment.
“We expect the stock to hold given its defensive qualities in what we expect to be a volatile environment but prefer to wait for a better entry point and/or clearer fundamental catalysts to put new money to work in it from here.”
Citi lowered its price target to $250, reflecting a valuation of 22.4x its 2026 earnings estimate, slightly below CME's three-year forward price-to-earnings average.
The bank revised its 2025 EPS estimate to $10.47 from $10.56 and introduced a 2027 forecast of $11.86, citing updated volume and pricing trends.
Related Articles
Citi downgrades CME to neutral on slower growth outlook
Super Micro stock soars 16%, eyes $38 resistance level
Canada PM Trudeau says he will step down after new Liberal party leader named
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.